Ob/Gyn Panel Reassured By Conceptus Essure Data, Recommends Caveats

Conceptus will ask FDA to drop a labeling requirement that a hysterosalpingogram (HSG) be performed three months after Essure placement, in the event that the condition accompanies approval of the non-incisional permanent birth control device